Q2 2024 Earnings Forecast for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By Wedbush

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Analysts at Wedbush lowered their Q2 2024 earnings estimates for shares of Fennec Pharmaceuticals in a report released on Monday, March 18th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of $0.09 for the quarter, down from their prior forecast of […]

Leave a Reply

Your email address will not be published.

Previous post Throwback Thursday
Next post Traders Buy Large Volume of Call Options on NXP Semiconductors (NASDAQ:NXPI)